dimethyl fumarate neuraxpharm
laboratorios lesvi s.l. - dimetyylifumaraatti - multippeliskleroosi, relapsoiva-remittoiva - immunosuppressantit - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
veramacor 2.5 mg/ml injektio-/infuusioneste, liuos
macure pharma aps - verapamil hydrochloride - injektio-/infuusioneste, liuos - 2.5 mg/ml - verapamiili
orlistat sandoz 60 mg kapseli, kova
sandoz a/s - orlistate - kapseli, kova - 60 mg - orlistaatti
sitagliptin orion 25 mg tabletti, kalvopäällysteinen
orion corporation - sitagliptin hydrochloride monohydrate - tabletti, kalvopäällysteinen - 25 mg - sitagliptiini
sitagliptin orion 50 mg tabletti, kalvopäällysteinen
orion corporation - sitagliptin hydrochloride monohydrate - tabletti, kalvopäällysteinen - 50 mg - sitagliptiini
sitagliptin orion 100 mg tabletti, kalvopäällysteinen
orion corporation - sitagliptin hydrochloride monohydrate - tabletti, kalvopäällysteinen - 100 mg - sitagliptiini
ranivisio
midas pharma gmbh - ranibitsumabi - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - silmätautien - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).
efavirenz aurobindo 600 mg tabletti, kalvopäällysteinen
aurobindo pharma (malta) ltd - efavirenz - tabletti, kalvopäällysteinen - 600 mg - efavirentsi
valganciclovir orion 450 mg tabletti, kalvopäällysteinen
aurobindo pharma (malta) ltd - valganciclovir hydrochloride - tabletti, kalvopäällysteinen - 450 mg - valgansikloviiri